Douglas P. Zmolek, M.D. Curriculum Vitae

Education
Graduate: Marquette University, Milwaukee, WI 1981
Post Graduate - MD: University of Wisconsin, Madison, WI 1985
Internship
State University of New York
Health Science Center
Syracuse, NY 1986
Residency
State University of New York
Health Science Center
Syracuse, NY 1988
License
State of New York License #171120-1 1988
Board Certification
American Board of Internal Medicine 1988
Professional Experience
Principal Investigator
Central NY Clinical Research
Manlius, NY 1996 to present
Private Practice Physician
Crouse Medical Practice

Private Practice Physician
CNY Internists
Manlius, NY

Manlius, NY
2015-present

1996 to 2014

Research Training

  • GCP Training via CITI Program 
  • NIH Protection of Human Participants Certificate 

Research Grants

  • Hyperlipidemia (Amgen) 4 studies
  • ZostaVax (Merck) 4 studies
  • Binge Eating Disorder (Alkermes)
  • Osteoarthritis Knee (Watson)
  • Obesity (Janssen, Shionogi)
  • Osteoarthritis-Knee (Lilly)
  • Chronic LBP (Pfizer)
  • Osteoporosis (Novartis)
  • Dyslipidemia (Sanofi-Aventis)
  • Constipation (Sucampo)
  • Osteoarthritis (McNeil)
  • Migraine (GSK) 2 studies
  • Hypertension (Novartis)
  • Diabetes/ Hypertension (Pfizer)
  • Migraine (Glaxo SmithKline)
  • Hyperlipidemia (Merck)
  • Asthma (Aventis)
  • Constipation (Sucampo)
  • Migraine (Eisai)
  • Insomnia (Takeda) 2 studies
  • Osteoarthritis (Novartis) 4 studies
  • Osteoarthritis-Vioxx (Merck)
  • Hyperlipidemia-Lipitor (Pfizer)
  • Migraine- 4 studies(Pharmacia)
  • Hyperlipidemia (Pharmacia)
  • Eplerenone-Hypertension (Searle) 3 studies
  • Common Cold (Viropharma)
  • Irritable Bowel Syndrome (TAP)
  • Meningitis Vaccine (Pfizer)
  • Smoking Cessation (Pfizer)
  • Diabetes/Htn (BMS)
  • Obesity (Orexigen)
  • Overactive Bladder (Pfizer)
  • Obesity (Sanofi-Synthelabo)
  • Migraine (Pozen)
  • Osteoarthritis (Pfizer)
  • Skin Infection (GSK)
  • Relpax-Migraines (Pfizer) 3 studies